Clinical Trial Update: Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China [Phase 3]

View source ↗

Summary

Phase 3 trial of eculizumab in pediatric and adult participants with atypical hemolytic uremic syndrome in China has completed and results were posted in Decemb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome

Drugs mentioned

• SOLIRIS (eculizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Atypical Hemolytic Uremic | Phase 3 | Status: COMPLETED | Results posted: 2025-12-08